Background and Purpose: There are limited data to guide intensive care unit (ICU) versus dedicated stroke unit (SU) admission for intracerebral hemorrhage (ICH) patients. We hypothesized select patients can be safely cared for in SU versus ICU at lower costs. Methods: We conducted a retrospective cohort study of consecutive patients with predefined minor ICH (≤ 20 cm 3 , supratentorial, no coagulopathy) receiving care in either an ICU or an SU. Multiple linear regression and inverse probability weighting were used to adjust for differences in patient characteristics and nonrandom ICU versus SU assignment. The primary outcome was poor functional status at discharge (modified Rankin score [mRS] ≥ 3). Secondary outcomes included complications, discharge disposition, hospital length of stay, and direct inpatient costs. Results: The study population included 104 patients (41 admitted to the ICU and 63 admitted to the SU). After controlling for differences in baseline characteristics, there were no differences in poor functional outcome at discharge (93% vs 85%, P ¼ .26) or in mean mRS (2.9 vs 3.0, P ¼ .73). Similarly, there were no differences in the rates of complications (6% vs 10%, P ¼ .44), discharged dead or to a skilled nursing facility (8% vs 13%, P ¼ .59), or direct patient costs (US$7100 vs US$6200, P ¼ .33). Median length of stay was significantly longer in the ICU group (5 vs 4 days, P ¼ .01). Conclusions: This study revealed a shorter length of stay but no large differences in functional outcome, safety, or cost among patients with minor ICH admitted to a dedicated SU compared to an ICU.
Introduction
Allocation of intensive care unit (ICU) resources is a critical decision for both clinicians and policy makers. Utilization of ICUs has steadily increased. 1 Guidelines support the care of acute spontaneous intracerebral hemorrhage (ICH) patients in an ICU or a dedicated stroke unit (SU) with appropriate physician and nursing expertise, 2 given high rates of mortality at 30 days (45%) and death or disability at 90 days (74%-79%) following presentation. 3, 4 The ICU monitoring allows for early detection and management of life-threatening neurological or respiratory deterioration due to hematoma expansion, perihematoma edema, hydrocephalus (HCP), and seizure. supratentorial, small-volume ICH have 1-month mortality rates of 0% to 13% and 3-month death or dependency rates of 18% to 34%. 3, 8 These rates are similar to those associated with acute ischemic stroke, for which patients are regularly managed in a general hospital ward or specialized SU. Smaller volume ICH without risk factors for hematoma expansion such as vascular malformation, coagulopathy, or severe hypertension does not have the same natural history as larger volume ICH. [9] [10] [11] For this subgroup of patients, ICU-level monitoring may not offer additional benefits associated with ICU care of more severe ICH patients. However, there is no evidence to guide level-of-care decisions for these less severe ICH patients. We hypothesized that carefully selected ICH patients can be safely managed in a dedicated SU rather than an ICU. The primary objectives of this study were to compare the rate of discharge with poor functional outcome (defined as actual or estimated modified Rankin score [mRS] 3) and to assess estimated direct inpatient costs for SU-versus ICU-admitted ICH patients who met predetermined criteria for admission to the SU.
Methods

Ethics Approval
Approval was obtained from the local institutional review board for all aspects of the study. A waiver of informed consent was granted.
Patient Selection
Consecutive patients aged 18 admitted to a single large tertiary care facility with a diagnosis of ICH were screened retrospectively. Patients with small-volume ICH (20 cm   3 ), supratentorial location, lack of coagulopathy, and presentation within 24 hours from symptom onset were included in the study. The ICU group consisted of patients admitted to the medical or neuroscience ICU from August 1, 2008, through February 1, 2012, prior to the opening of a dedicated SU at our institution. The SU group included patients admitted from August 1, 2012, through January 30, 2014, starting 6 months after SU opening. Medical ICU care was conducted by a team led by a medical intensivist. The ICH-specific recommendations were provided via neurology consultation. All aspects of care in the neuroscience ICU were managed by a team led by a neurointensivist. Nurses in both ICUs are trained in intensive and neurological care and have a nursing ratio of 2:1. Ventilator support and use of continuous intravenous vasopressors, inotropes, and antihypertensive drugs are routine. Extraventricular cerebrospinal fluid drainage via ventriculostomy and hyperosmotic therapy is also common. Vital signs and neurological checks are hourly but can be more frequent as needed. Care in the SU consists of management by a team led by a neurologist. Nurses have specialized stroke expertise and are staffed at a nursing ratio of 3:1 with ability to flex to a more intensive ratio depending on patient acuity. This is a less intensive ratio than that of the ICU but more intensive than that of standard wards. Routine vital signs and neurological checks vary from hourly to every 8 hours but can be more frequent as needed. Use of continuous intravenous antihypertensive drips is routine, but vasopressors and inotropes are not allowed. Ventilator support, ventriculostomy, and hyperosmotic therapy are not performed in the SU. Interdisciplinary teams in both locations include physical, occupational, and speech therapists; a clinical social worker; and a case manager. General ICH care is driven by the same institutional and national guidelines and directed by members of the same neurology faculty in both ICUs and the SU.
Data Collection
Medical records of all ICH patients admitted during each study period were screened by study personnel (K.M.G., C.R.F., and B.B.T.). Those meeting criteria were reviewed in detail for all demographic characteristics, medical history, medications, and clinical (Glasgow Coma Scale [GCS] score and National Institutes of Health Stroke Scale [NIHSS] score), laboratory, and imaging data. The ICH volume was calculated by the simplified ABC/2 method, and location was dichotomized as deep or lobar by 2 independent reviewers (C.R.F. and B.B.T.). [12] [13] [14] Other imaging characteristics obtained included presence of subarachnoid blood, intraventricular hemorrhage (IVH), presence of HCP, and degree of midline shift at the septum pellucidum and pineal body. Suspected ICH etiology at the time of initial presentation was classified as hypertensive angiopathy, cerebral amyloid angiopathy, other, or not documented. The ICH score, Functional Outcome Risk Stratification Scale (FUNC) score, and Charlson comorbidity index were calculated as summary measures of the aforementioned data. 3, 8, 15 Study personnel were not blinded to admission unit.
Outcomes
Primary outcome was poor functional outcome at the time of discharge which was defined as mRS 3. Secondary outcomes included complications (ICH expansion [defined as an increase in hematoma volume >33%], 16 clinical or electrographic seizure, pneumonia [per medical team diagnosis], endotracheal intubation, placement of an external ventricular drain, craniotomy or craniectomy with or without hematoma evacuation, institution of osmotherapy, vasopressor or inotrope use, unplanned noncontrast head computed tomography [CT; as a surrogate for significant neurological deterioration], or transfer to an ICU), discharge disposition (home, home with services, acute inpatient rehabilitation, skilled nursing facility, hospice, death), hospital length of stay (LOS) in days, and direct inpatient costs. Direct costs were calculated by our hospital's finance department based upon charges (in US dollars) associated with each patient's episode of care during the index hospitalization without adjustment for inflation. They incorporate the cost of running each unit, but not the cost of establishing each unit.
Statistical Analysis
A sample size of 64 patients per group for a total sample size of 128 was targeted to detect a moderate effect size with a type I error of 5% and a power of 80%. Univariate comparisons between groups utilized the w 2 test for categorical variables and Wilcoxon rank sum for continuous variables. Generalized linear regression models were used to describe differences in LOS (quantile regression), costs (log-normal), discharge mRS (logistic for mRS 3 and linear for mRS), and complications (logistic). A complication was operationally defined as a dichotomous variable representing incidence of any of the following: ICH expansion, seizure, pneumonia, neurosurgical procedure, osmotherapy, vasopressor or inotrope use, or unplanned head CT. Confounders were identified a priori based on clinical judgment and checked for collinearity. Confounders for each model included age, sex, race, prior disability, presence of IVH, HCP, presenting NIHSS score, presenting GCS score, and ICH volume >10 cm 3 . Models for mRS outcome also used FUNC score as a confounder.
Given the lack of random allocation, inverse probability weights (IPWs) based on identified confounders were used to adjust for differences in factors relating to predefined study outcomes. Outcome models used both IPW and regression adjustment (double-robust estimation). 17 All analyses were performed using STATA version 14.1 (College Station, Texas).
Results
There were 420 ICH patients screened and 104 patients included in the analysis (41 ICU [6 medical ICU and 35 neuroscience ICU] and 63 SU). A complete description of baseline demographic and clinical characteristics for the ICU and SU groups is provided in Table 1 . Mean age was 65 (SD +18) years in the ICU group and 70 (SD +14) years in the SU group (P ¼ .15). Female gender was more common in the ICU group, though this difference did not reach statistical significance (54% vs 35%, P ¼ .06). Distribution of race did not differ between groups. There were fewer patients without insurance (15% vs 41%) and more patients with private insurance (24% vs 8%) in the ICU relative to the SU (P ¼ .009). Systolic blood pressure was similar in the 2 groups (172 vs 171 mm Hg, P ¼ .80). Mean GCS score was lower (13.7 vs 14.7, P ¼ .004) and NIHSS score was higher (9.6 vs 5.9, P < .001) in the ICU group. The ICH volume was higher (8.4 cm 3 vs 5.7 cm 3 , P ¼ .01) and IVH (42% vs 10%, P < .001) and HCP (15% vs 1.6%, P ¼ .009) were more common in the ICU group.
Univariate analysis of primary and secondary outcomes is provided in Table 2 . There were no deaths in the ICU group and 2 in the SU group. Poor functional outcome at discharge (mRS 3) was more common in the ICU group than in the SU group, but this difference did not reach statistical significance (76% vs 57%, P ¼ .06). There were no significant differences in complications such as ICH expansion, seizure, pneumonia, or need for osmotic therapy. Unfavorable discharge disposition (dead or to a skilled nursing facility) was similar between groups (20% vs 13%, P ¼ .35). The median LOS was significantly longer in the ICU group (6 days) than in the SU group (3 days, P < .001), and the mean direct hospital costs were also greater in the ICU group (US$12 500) than in the SU group (US$6500, P ¼ .01).
The results of multivariate linear regression adjusting for differences in baseline patient characteristics and IPW to account for nonrandom assignment of the ICU versus SU groups are reported in Table 2 . There was no significant difference in the primary outcome of functional status at discharge between groups. Among secondary outcomes, there remained a significant difference in median LOS (5 days in ICU and 4 days in SU, P ¼ .01). The number of complications, discharge status, and costs did not differ between groups. It should be noted that point estimates do not always favor SU over ICU as they do in the unadjusted analyses.
Discussion
This study provides evidence that patients with favorable ICH characteristics can be admitted to a dedicated SU in lieu of an ICU with similar safety despite less intensive nursing ratios and monitoring. These results address a critical gap in evidence guiding recommendations for level of care for ICH patients. Our single-center study should be interpreted with caution, given it was not designed as a noninferiority trial, and the target sample size to detect moderate differences between groups was not met. Lack of study power was due to an overestimation of the proportion of all ICH patients who would meet the inclusion criteria. As a result, only large differences between groups could be determined. Despite these limitations, there were comparable outcomes and costs and more favorable LOS for ICH patients admitted to the SU. Our findings support the safety of what may already be in practice at many centers and provide an empirical basis for larger confirmatory studies. The 2010 American Heart Association/ American Stroke Association guidelines for management of patients with ICH recommended admission to an ICU with physician and nursing neuroscience acute care expertise. 18 The 2015 guidelines added a dedicated SU as an acceptable admission unit based largely upon recognition that the practice may be common without high-level evidence. 2, 19 The SU care as opposed to general ward care has been shown to benefit ICH patients, reducing the risk of death and dependency by more than 20%. 20 Similarly, admission to a general ICU as opposed to a dedicated neuroscience ICU has been shown to result in 3.4 times higher odds of death. 21 However, to our knowledge, a direct comparison between admission to an ICU and a SU has not previously been performed in this patient population.
In keeping with less severe clinical status and low comorbidity, there were few deaths in our study. Discharge outcomes were similar between the groups and remained unchanged when corrected for admission markers of clinical severity, including GCS score, NIHSS score, IVH, and HCP. Complications also did not differ between groups (6% in the ICU vs 10% in the SU, P ¼ .44). Observed and adjusted estimates are derived from generalized linear model, and adjusted models include adjustment for age, sex, race, prior disability, presence of IVH, HCP, presenting NIHSS score, presenting GCS score, and ICH volume >10 cm 3 . Models for mRS outcome were also adjusted for FUNC score. Adjustment is by both IPW and regression adjustment (double robust estimation).
In univariate analysis, better outcomes and significantly lower LOS and direct patient costs were observed in the SU group as compared to the ICU group. The unequal baseline characteristics of our sample suggest that physicians were reluctant to admit patients with markers of more significant disease to the SU despite not being part of predetermined SU admission criteria (identical to study inclusion criteria, pragmatically determined as a more conservative approximation of the ICH score). As with all clinical guidelines, physician judgment based on individual patient characteristics must remain paramount. The discretion of the admitting physician team is evidenced in our study by significantly fewer patients with IVH or HCP in the SU group. It is possible that our SU admission guidelines should be modified to reflect this practice. The SU group patients also had higher GCS scores, lower NIHSS scores, and lower ICH Scores compared with patients in the ICU group. Lower patient ascertainment in the ICU group despite a longer study period for acquisition may suggest that practice at our institution was to admit patients with relatively small ICH to the general neurology ward even prior to the establishment of our SU and the publication of the revised ICH guidelines. 2 Imbalance between groups is a common limitation of nonrandomized studies because a variety of factors contribute to group assignment. We used IPW and model-specific covariates (double robust estimation) to address this concern. After adjusting for these differences between groups, a significant reduction in LOS remained. All other predefined outcomes, including functional status, complications, and costs, did not differ between ICU and SU care. A larger prospective multicenter study would provide additional evidence for the potential safety, reduced costs, and lower LOS of SU admission for relatively mild ICH patients.
One previous study reported the results of 20 mild ICH patients admitted to a step-down unit but without a comparator group admitted to a higher intensity unit. 22 Mortality and complications were similarly low in that study, suggesting that ours is not a center-specific finding. One patient who would have been excluded from our study due to an ICH volume of 47 cm 3 died in that cohort. Another study comparing admission of a broad range of neurological diagnoses to an intermediate care neuroscience unit versus an ICU reported decreased LOS with similar mortality in the intermediate care unit. However, in that study, the intermediate care unit utilized a daytime neurocritical care specialist, had a nursing ratio of 2:1, had the capacity to deliver both continuous blood pressure-lowering and blood pressure-raising medications, and manage ventriculostomies, all more typical of an ICU. 6 In a third study, predictors of the need for ICU-level care, defined as requirement for ventilator or hyperosmolar therapy, need for a neurosurgical procedure, or significant clinical decline leading to palliative care or death, were explored. The ICH volume 30 cm 3 , GCS <13, and the presence of IVH were found to be predictive. 7 This is similar to the factors associated with ICU admission in our study.
It is possible that ICH care in general changed over time during the study period. This is an intrinsic limitation to our study design. This study was conducted at a tertiary care comprehensive stroke center, which may limit the generalizability to smaller centers with less robust neuroscience support structure. Another limitation is that our study size did not allow for comparison of outcomes between medical ICU and neuroscience ICU admission.
Conclusion
This study did not reveal large differences in functional outcome, safety, or cost among select patients with relatively minor ICH admitted to a dedicated SU compared to an ICU. The LOS was shorter for minor ICH patients admitted to an SU.
